Anti-PLD6 monoclonal antibody

Pre-made anti-PLD6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PLD6/PLD6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1411-Ab-1/ GM-Tg-hg-IP1411-Ab-2Anti-Human PLD6 monoclonal antibodyHuman
GM-Tg-rg-IP1411-Ab-1/ GM-Tg-rg-IP1411-Ab-2Anti-Rat PLD6 monoclonal antibodyRat
GM-Tg-mg-IP1411-Ab-1/ GM-Tg-mg-IP1411-Ab-2Anti-Mouse PLD6 monoclonal antibodyMouse
GM-Tg-cynog-IP1411-Ab-1/ GM-Tg-cynog-IP1411-Ab-2Anti-Cynomolgus/ Rhesus macaque PLD6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1411-Ab-1/ GM-Tg-felg-IP1411-Ab-2Anti-Feline PLD6 monoclonal antibodyFeline
GM-Tg-cang-IP1411-Ab-1/ GM-Tg-cang-IP1411-Ab-2Anti-Canine PLD6 monoclonal antibodyCanine
GM-Tg-bovg-IP1411-Ab-1/ GM-Tg-bovg-IP1411-Ab-2Anti-Bovine PLD6 monoclonal antibodyBovine
GM-Tg-equg-IP1411-Ab-1/ GM-Tg-equg-IP1411-Ab-2Anti-Equine PLD6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1411-Ab-1/ GM-Tg-hg-IP1411-Ab-2; GM-Tg-rg-IP1411-Ab-1/ GM-Tg-rg-IP1411-Ab-2;
GM-Tg-mg-IP1411-Ab-1/ GM-Tg-mg-IP1411-Ab-2; GM-Tg-cynog-IP1411-Ab-1/ GM-Tg-cynog-IP1411-Ab-2;
GM-Tg-felg-IP1411-Ab-1/ GM-Tg-felg-IP1411-Ab-2; GM-Tg-cang-IP1411-Ab-1/ GM-Tg-cang-IP1411-Ab-2;
GM-Tg-bovg-IP1411-Ab-1/ GM-Tg-bovg-IP1411-Ab-2; GM-Tg-equg-IP1411-Ab-1/ GM-Tg-equg-IP1411-Ab-2
Products NameAnti-PLD6 monoclonal antibody
Formatmab
Target NamePLD6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PLD6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1411-Ag-1Recombinant multi-species PLD6/ ZUC protein
    ORF Viral VectorvGMLP004650human PLD6 Lentivirus particle
    ORF Viral VectorpGMLP004650human PLD6 Lentivirus plasmid
    ORF Viral VectorpGMLPm005118mouse Pld6 Lentivirus plasmid
    ORF Viral VectorvGMLPm005118mouse Pld6 Lentivirus particle


    Target information

    Target IDGM-IP1411
    Target NamePLD6
    Gene ID201164,194908,287366,703931,489545,101088529,526651,100052895
    Gene Symbol and Synonyms4933433K01Rik,Gm10,mitoPLD,mZuc,PLD6,RGD1311987,ZUC
    Uniprot AccessionQ8N2A8,E2RD63,E1BE10
    Uniprot Entry NamePLD6_HUMAN,PLD6_CANLF,PLD6_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000179598
    Target ClassificationN/A

    The target: PLD6, gene name: PLD6, also named as ZUC. Enables cardiolipin hydrolase activity and protein homodimerization activity. Involved in mitochondrial fusion. Acts upstream of or within positive regulation of mitochondrial fusion. Located in mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.